Statement Of Cash Flows [Abstract]

ORPEA - Filing #2810692

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
103,000,000,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issue of ordinary shares
1 160 080 EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.